Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide.
Flawless balance sheet with reasonable growth potential.
Share Price & News
How has Nexus's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NXU's share price has been volatile over the past 3 months.
7 Day Return
DE Healthcare Services
1 Year Return
DE Healthcare Services
Return vs Industry: NXU exceeded the German Healthcare Services industry which returned 6.4% over the past year.
Return vs Market: NXU exceeded the German Market which returned 0.3% over the past year.
Price Volatility Vs. Market
How volatile is Nexus's share price compared to the market and industry in the last 5 years?
Simply Wall St News
5 days ago | Simply Wall StIs Nexus AG's (ETR:NXU) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
3 weeks ago | Simply Wall StCalculating The Fair Value Of Nexus AG (ETR:NXU)
1 month ago | Simply Wall StNexus AG’s (ETR:NXU) Investment Returns Are Lagging Its Industry
Is Nexus undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NXU (€39.5) is trading below our estimate of fair value (€40.64)
Significantly Below Fair Value: NXU is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: NXU is poor value based on its PE Ratio (56.8x) compared to the Healthcare Services industry average (15.9x).
PE vs Market: NXU is poor value based on its PE Ratio (56.8x) compared to the German market (20.5x).
Price to Earnings Growth Ratio
PEG Ratio: NXU is poor value based on its PEG Ratio (2.4x)
Price to Book Ratio
PB vs Industry: NXU is overvalued based on its PB Ratio (5.5x) compared to the DE Healthcare Services industry average (3.7x).
How is Nexus forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NXU's forecast earnings growth (23.2% per year) is above the savings rate (0.2%).
Earnings vs Market: NXU's earnings (23.2% per year) are forecast to grow faster than the German market (22.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: NXU's revenue (6.1% per year) is forecast to grow faster than the German market (5.9% per year).
High Growth Revenue: NXU's revenue (6.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: NXU's Return on Equity is forecast to be low in 3 years time (12%).
How has Nexus performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NXU has high quality earnings.
Growing Profit Margin: NXU's current net profit margins (7.1%) are lower than last year (7.7%).
Past Earnings Growth Analysis
Earnings Trend: NXU's earnings have grown by 7% per year over the past 5 years.
Accelerating Growth: NXU's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NXU had negative earnings growth (-1.5%) over the past year, making it difficult to compare to the Healthcare Services industry average (-1.5%).
Return on Equity
High ROE: NXU's Return on Equity (10.5%) is considered low.
How is Nexus's financial position?
Financial Position Analysis
Short Term Liabilities: NXU's short term assets (€94.7M) exceed its short term liabilities (€68.9M).
Long Term Liabilities: NXU's short term assets (€94.7M) exceed its long term liabilities (€45.9M).
Debt to Equity History and Analysis
Debt Level: NXU is debt free.
Reducing Debt: NXU has no debt compared to 5 years ago when its debt to equity ratio was 5.3%.
Debt Coverage: NXU has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NXU has no debt, therefore coverage of interest payments is not a concern.
What is Nexus's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: NXU's dividend (0.46%) isn’t notable compared to the bottom 25% of dividend payers in the German market (1.26%).
High Dividend: NXU's dividend (0.46%) is low compared to the top 25% of dividend payers in the German market (3.83%).
Stability and Growth of Payments
Stable Dividend: NXU is not paying a notable dividend for the German market, therefore no need to check if payments are stable.
Growing Dividend: NXU is not paying a notable dividend for the German market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: NXU is not paying a notable dividend for the German market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NXU's dividend in 3 years as they are not forecast to pay a notable one for the German market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Dr. Ingo Behrendt, MBA serves as the Chairman of the Executive Board and Chief Executive Officer at Nexus AG.
CEO Compensation Analysis
Compensation vs Market: Ingo's total compensation ($USD1.29M) is about average for companies of similar size in the German market ($USD1.43M).
Compensation vs Earnings: Ingo's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
|Member of the Supervisory Board||5.17yrs||no data||no data|
|Member of the Supervisory Board||1.17yrs||no data||no data|
|Member of the Supervisory Board||14.08yrs||no data||no data|
|Deputy Chairman of the Supervisory Board||8.17yrs||no data||no data|
|Chairman of the Supervisory Board||no data||no data||no data|
|Member of Supervisory Board||1.17yrs||no data||no data|
|Substitute Supervisory Board Member||no data||no data||no data|
|Substitute Supervisory Board Member||no data||no data||no data|
Experienced Board: NXU's board of directors are considered experienced (5.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Nexus AG's company bio, employee growth, exchange listings and data sources
- Name: Nexus AG
- Ticker: NXU
- Exchange: XTRA
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €622.084m
- Shares outstanding: 15.75m
- Website: https://de-de.nexus-ag.de
Number of Employees
- Nexus AG
- Irmastrasse 1
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NXU||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Jul 2000|
|NXU||XTRA (XETRA Trading Platform)||Yes||Ordinary Shares||DE||EUR||Jul 2000|
|0FGL||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||EUR||Jul 2000|
|NXU||SWX (SIX Swiss Exchange)||Yes||Ordinary Shares||CH||CHF||Jul 2000|
|NXUd||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||EUR||Jul 2000|
Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and TESIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/ESKULAP and NEXUS/EPD for somatic and psychiatric institutions; NEXUS/VITA and TESIS VITA for in-vitro clinics; NEXUS/HOME for senior citizen and nursing homes; Emed, a Web-based hospital information system; NEXUS/REHA for rehabilitation facilities; NEXUS/PAT(CH), an administration system for hospitals; NEXUS/GYNECOLOGY for obstetric institutes and gynecology; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUS/INFORMATION STORE, a management information system for hospitals; NEXUS/QM for quality management in the healthcare system; and NEXUS/CSSD, NEXUS/SPM, and EuroSDS for product sterilization processes in hospitals. Its information systems also comprise NEXUS/INTEGRATIONSERVER for interface management; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical diagnostics and device integration; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/SWITSPOT software solutions; ASS.TEC for process and HR consulting in SAP environment; highsystemNET life cycle client management; CREATIVE OM, CRM solution; and NEXUS/Cloud IT, outsourcing solutions in healthcare. In addition, the company offers NEXUS/MOBILE for device management, app monitoring, communication, and HIS integration, as well as NEXUS/ECM, NEXUS/E&L, NEXUS/CHILI, NEXUS/PDMS, NEXUS/RIS/PACS, and NEXUS/FOODCARE. NEXUS AG is headquartered in Donaueschingen, Germany.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/04 21:03|
|End of Day Share Price||2020/07/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.